Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E BRANDSTRUP

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|March 19, 2010
Foetal and neonatal mortalityA H DAVIDSON, E BRANDSTRUP
The Journal of Rheumatology|January 1, 1982
Pirprofen (Rengasil) in the treatment of juvenile rheumatoid arthritis. A segment I studyJ C Bass, E H Giannini, E J Brewer, et al.
The Journal of Rheumatology|April 1, 1985
A once-daily antiinflammatory drug, oxaprozin, in the treatment of juvenile rheumatoid arthritis. The Pediatric Rheumatology Collaborative Study GroupJ C Bass, B H Athreya, E J Brewer, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|March 19, 2010
Foetal and neonatal mortalityA H DAVIDSON, E BRANDSTRUP
The Journal of Rheumatology|January 1, 1982
Pirprofen (Rengasil) in the treatment of juvenile rheumatoid arthritis. A segment I studyJ C Bass, E H Giannini, E J Brewer, et al.
The Journal of Rheumatology|April 1, 1985
A once-daily antiinflammatory drug, oxaprozin, in the treatment of juvenile rheumatoid arthritis. The Pediatric Rheumatology Collaborative Study GroupJ C Bass, B H Athreya, E J Brewer, et al.
Pageof 1